Compared with the LPS-only group, LPS+RvD1 treatment showed a trend toward reduced IL-6 expression and increased IL-10 expression, although these changes did not reach statistical significance ( p = 0.1218 and p = 0.1155, respectively).
← all excerpts
Resolvin D1 in the Lipopolysaccharide-Induced Inflammatory Microenvironment Mediates Resolution in Human Monocytic THP-1 Cells.
1
—
—